Cryptogenic organizing pneumonia epidemiology and demographics
|
Cryptogenic Organizing Pneumonia Microchapters |
|
Differentiating Cryptogenic organizing pneumonia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Cryptogenic organizing pneumonia epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Cryptogenic organizing pneumonia epidemiology and demographics |
|
FDA on Cryptogenic organizing pneumonia epidemiology and demographics |
|
CDC on Cryptogenic organizing pneumonia epidemiology and demographics |
|
Cryptogenic organizing pneumonia epidemiology and demographics in the news |
|
Blogs on Cryptogenic organizing pneumonia epidemiology and demographics |
|
Directions to Hospitals Treating Cryptogenic organizing pneumonitis |
|
Risk calculators and risk factors for Cryptogenic organizing pneumonia epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Overview
Epidemiology and Demographics
Reported incidence is 0.01%, but COP may be more common and underdiagnosed. The mortality rate is approximately 7%, although these tend to be the elderly or those in poor health from other conditions.
Age
It usually begins between the ages of 40 and 60.
Gender
It affects men and women equally.
|
Xyz Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cryptogenic organizing pneumonia epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Cryptogenic organizing pneumonia epidemiology and demographics |
|
FDA on Cryptogenic organizing pneumonia epidemiology and demographics |
|
CDC on Cryptogenic organizing pneumonia epidemiology and demographics |
|
Cryptogenic organizing pneumonia epidemiology and demographics in the news |
|
Blogs on Cryptogenic organizing pneumonia epidemiology and demographics |
|
Risk calculators and risk factors for Cryptogenic organizing pneumonia epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]; Associate Editor(s)-in-Chief:
Overview
Epidemiology and Demographics
Incidence
- The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
- In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
Prevalence
- The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
- In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
- The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
Case-fatality rate/Mortality rate
- In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
- The case-fatality rate/mortality rate of [disease name] is approximately [number range].
Age
- Patients of all age groups may develop [disease name].
- The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
- [Disease name] commonly affects individuals younger than/older than [number of years] years of age.
- [Chronic disease name] is usually first diagnosed among [age group].
- [Acute disease name] commonly affects [age group].
Race
- There is no racial predilection to [disease name].
- [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
Gender
- [Disease name] affects men and women equally.
- [Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
Region
- The majority of [disease name] cases are reported in [geographical region].
- [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].